What is the current status of GW Pharmaceuticals products under development?
GW now has completed its first wave of Phase III clinical trials, all of which reported positive findings. GW has further Phase II and III studies underway which can be viewed as a pipeline diagram by clicking here. Alternatively for a review of GW’s clinical trials please click Phase II or Phase III as appropriate.
